Funder
National Institute for Health and Care Research
UCLH Biomedical Research Centre
Subject
Nutrition and Dietetics,Endocrinology, Diabetes and Metabolism
Reference46 articles.
1. Anti-CD19 CAR T-cell therapy for B-cell non-Hodgkin lymphoma;Abramson;Transfusion Medicine Reviews,2020
2. What do Participants Want? The Importance of Participant-reported Outcomes;Schoemans,2022
3. Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study. Blood;Crump;The Journal of the American Society of Hematology,2017
4. Participant-reported outcomes with chimeric antigen receptor T cell therapy: challenges and opportunities;Chakraborty;Biology of Blood and Marrow Transplantation,2019
5. Lisocabtagene maraleucel for participants with relapsed or refractory large B-cell lymphomas (TRANSCEND NHL 001): a multicentre seamless design study;Abramson;The Lancet,2020